Page last updated: 2024-11-06

prednisolone and Leukocyte-Adhesion Deficiency Syndrome

prednisolone has been researched along with Leukocyte-Adhesion Deficiency Syndrome in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Leukocyte-Adhesion Deficiency Syndrome: Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (RECEPTORS, LEUKOCYTE-ADHESION) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedlow, AJ1
Davies, EG1
Moss, AL1
Rebuck, N1
Finn, A1
Marsden, RA1

Other Studies

1 other study available for prednisolone and Leukocyte-Adhesion Deficiency Syndrome

ArticleYear
Pyoderma gangrenosum in a child with congenital partial deficiency of leucocyte adherence glycoproteins.
    The British journal of dermatology, 1998, Volume: 139, Issue:6

    Topics: CD11 Antigens; CD18 Antigens; Child, Preschool; Female; Glucocorticoids; Humans; Leukocyte-Adhesion

1998